US 12,029,641 B2
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
Robert D. Rehnke, St. Petersburg, FL (US)
Assigned to Bard Shannon Limited, Humacao, PR (US)
Filed by Bard Shannon Limited, Humacao, PR (US)
Filed on Apr. 21, 2021, as Appl. No. 17/236,205.
Application 17/236,205 is a continuation of application No. 16/827,030, filed on Mar. 23, 2020, granted, now 11,638,640.
Prior Publication US 2021/0290366 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/12 (2006.01); A61L 27/36 (2006.01); A61F 2/00 (2006.01)
CPC A61F 2/12 (2013.01) [A61L 27/3604 (2013.01); A61F 2002/0081 (2013.01); A61F 2210/0004 (2013.01); A61F 2230/0069 (2013.01); A61F 2230/0071 (2013.01); A61F 2240/002 (2013.01); A61F 2250/0023 (2013.01)] 18 Claims
OG exemplary drawing
 
1. An implantable prosthesis comprising:
a tissue infiltratable body of biocompatible material having a three-dimensional configuration with a longitudinal axis, the body being formed of mesh fabric, the body including:
a plurality of chambers arranged circumferentially about the longitudinal axis, the plurality of chambers arranged to face in an outward radial direction transverse to the longitudinal axis, the plurality of chambers being arranged and connected to stabilize compression and tension forces exerted on the body by tissue and/or muscle when implanted in a human body.